I am a
Home I AM A Search Login

Papers of the Week

Papers: 4 Jun 2022 - 10 Jun 2022

Pharmacology/Drug Development

2022 Mar

Future Sci OA



Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.


Bates D, Vivian D, Freitag J, Wickham J, Mitchell B, Verrills P, Shah K, Boyd R, Federman D, Barnard A, O'Connor L, Young JF
Future Sci OA. 2022 Mar; 8(5):FSO794.
PMID: 35662742.


To evaluate safety and efficacy of low dose autologous adipose-derived mesenchymal stem cells (ADMSCs) for treatment of disc degeneration resulting in low back pain (LBP).